Banner MD Anderson Cancer Center - Academic Profile

Publications

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Frederick L. Locke , Armin Ghobadi , Caron A. Jacobson +28 more

Axicabtagene ciloleucel is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. In the previous analysis of the ZUMA-1 registrational study, with a median fol...

2018 The Lancet Oncology 2108 citations

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden , Danny Rischin , Chrysalyne D. Schmults +34 more

Among patients with advanced cutaneous squamous-cell carcinoma, cemiplimab induced a response in approximately half the patients and was associated with adverse events that usua...

2018 New England Journal of Medicine 1322 citations

Affiliated Researchers

Javier Muñoz

Banner MD Anderson Cancer Center

Jiaxin Niu

Banner MD Anderson Cancer Center

Institution Info

Type: healthcare
Country: N/A
Publications: 2
Citations: 3,430

External Links

Identifiers

ROR: https://ror.org/049c9q337